Skip to main content

Table 2 Antibiotic regimens therapy during hospitalization

From: Bloodstream infections caused by ST2 Acinetobacter baumannii: risk factors, antibiotic regimens, and virulence over 6 years period in China

Antimicrobial Total (n = 108) Nonsurvivor (n = 75) Survivor (n = 33)
Antibiotic usage during hospitalization, n (%)    
 Carbapenem 92 (85.2) 66 (88.0) 26 (78.8)
  Cefoperazone/sulbactam 75 (69.4) 49 (65.3) 26 (78.8)
 Piperacillin/tazobactam 30 (27.8) 18 (24.0) 12 (36.4)
 Tigecycline 49 (45.4) 33 (44.0) 16 (48.5)
 Polymyxin B 8 (7.4) 4 (5.3) 4 (12.1)
Antibiotic regimens after positive blood culture, n (%)    
 Carbapenem 16 (14.8) 12 (16.0) 4 (12.1)
 Cefoperazone/sulbactam 14 (13.0) 10 (13.3) 4 (12.1)
 Tigecycline 6 (5.6) 6 (8.0) 0 (0)
  Carbapenem + Tigecycline 9 (8.3) 9 (12.0) 0 (0)
 Cefoperazone/sulbactam + Tigecycline 28 (25.9) 13 (17.3) 15 (45.5)
 Polymyxin B + Tigecycline 5 (4.6) 3 (4.0) 2 (6.1)